Skin Laxity
Conditions
Keywords
Ulthera® System, Ultherapy™ Treatment, Ulthera, Inc., Ultrasound treatment for skin tightening
Brief summary
Up to 30 subjects will be enrolled. All subjects will receive one Ultherapy treatment to the lower two thirds of the face and neck. Subjects will be equally grouped into those with a history of submentoplasty and or rhytidectomy and those naive to submentoplasty and or rhytidectomy. Follow-up visits will occur at 14, 30, 60, 90 and 180 days following treatment. Study images will be obtained pre-treatment, 30-60 minutes post-treatment, and at each follow-up visit.
Detailed description
This is a prospective single center study. Subjects will be enrolled one per group as they present. Efficacy will be determined by the change in submental volume and cervicomental angle. GAIS and patient satisfaction questionnaires will also be obtained.
Interventions
DEVICEUlthera System Treatment
Focused ultrasound energy delivered below the surface of the skin
Sponsors
Ulthera, Inc
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Male or female, aged 30 to 65 years * Subject in good health * Body Mass index of less than 30 * Present with unwanted skin laxity in the submental area as demonstrated by a grade 2 or 3 on the Knize scale for classification of cosmetic deformity of the cervicomental angle * Previous history of surgical submentoplasty and or rhytidectomy greater than 12 months previous to enrollment and not to exceed 120 months prior to enrollment * Understands and accepts the obligation not to receive any other procedures in the submental areas thru the 6 month follow up visit * Willingness and ability to comply with protocol requirements including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study * Subjects of childbearing potential must have a negative urine pregnancy test result at Visit 1 and be willing able to use an acceptable method of birth control
Exclusion criteria
* Pregnant, lactating or planning to become pregnant and or not using a reliable form of birth control * Has an active systemic or local skin disease that may alter wound healing * Subjects with a prior cosmetic or medical history of submentoplasty and or Rhytidectomy within the last 12 months or greater than 120 months * Subjects with a prior cosmetic or medical history of submentoplasty and or Rhytidectomy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in submental volume | 90 days post-treatment | Measured by the Canfield Vectra® imaging system comparing pre-treatment baseline photos to post-treatment photos. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall improvement of the submental area | 90 days post-treatment | Global Aesthetic Improvement Scale (GAIS) and patient satisfaction questionnaires will be obtained. |
Countries
United States
Outcome results
None listed